Sporotrichosis pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
''S. schenckii'' is usually transmitted via posttraumatic inoculation to the human host, however, infrequently sporotrichosis may also develop as a result of spore inhalation. | |||
==Pathophysiology== | ==Pathophysiology== | ||
===Transmission=== | ===Transmission=== | ||
Revision as of 16:27, 26 January 2016
|
Sporotrichosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sporotrichosis pathophysiology On the Web |
|
American Roentgen Ray Society Images of Sporotrichosis pathophysiology |
|
Risk calculators and risk factors for Sporotrichosis pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alison Leibowitz [2]
Overview
S. schenckii is usually transmitted via posttraumatic inoculation to the human host, however, infrequently sporotrichosis may also develop as a result of spore inhalation.
Pathophysiology
Transmission
- S. schenckii is usually transmitted to the human host via posttraumatic inoculation. However, sporotrichosis may also develop as a result of spore inhalation, although this mode of transmission is infrequent.
- Modes of transmission either lead to direct inoculation or enable the entry of the fungus.
- Actions, such as handling thorny plants, sphagnum moss, bales of hay, or any plant or plant product that can cause skin trauma, may enable S. schenckii entry.
Pathogenesis
- The pathophysiology of sporotrichosis depends on the histological subtype and the frequently nonspecific histopathology may mimic other granulomatous diseases.[1]
- S. schenckii is capable of modulating the immune response to promote its own survival by blocking cytokine production by macrophages.[2]
Cutaneous forms
- S. schecknii accesses the subcutaneous tissue following minor epidermal trauma.
- S. schecknii, a thermo-dependent fungus, converts into its yeast form upon entering the tissue.
- Fixed form
- The yeast form of S. schenckii stays localized in subcutaneous tissue
- Lymphocutaneous form
- The yeast form of S. schenckii extends through the nearby lymphatic vessels
- Disseminated cutaneous form
- Manifests upon the hematogenous dissemination of the yeast form of S. schenckii.
Extracutaneous/Systematic Forms
- Osteoarticular form
- May manifest upon contiguity or hematogenous spread.
- Pulmonary form
- Manifests following inhalation of S. schenckii spores
- Disseminated form
- Manifests upon the hematogenous dissemination of the yeast form of S. schenckii.[3]
References
- ↑ Mahajan VK (2014). "Sporotrichosis: an overview and therapeutic options". Dermatol Res Pract. 2014: 272376. doi:10.1155/2014/272376. PMC 4295339. PMID 25614735.
- ↑ Carlos IZ, Sassá MF, da Graça Sgarbi DB, Placeres MC, Maia DC (July 2009). "Current research on the immune response to experimental sporotrichosis". Mycopathologia. 168 (1): 1–10. doi:10.1007/s11046-009-9190-z. PMID 19241140.
- ↑ Barros MB, de Almeida Paes R, Schubach AO (2011). "Sporothrix schenckii and Sporotrichosis". Clin Microbiol Rev. 24 (4): 633–54. doi:10.1128/CMR.00007-11. PMC 3194828. PMID 21976602.